Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank37
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P37
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -30.32% |
| Q2 2025 | -44.27% |
| Q1 2025 | -5471.79% |
| Q4 2024 | 99.74% |
| Q3 2024 | -705.10% |
| Q2 2024 | -7.21% |
| Q1 2024 | 20.54% |
| Q4 2023 | -119.57% |
| Q3 2023 | -582.98% |
| Q2 2023 | 21152.71% |
| Q1 2023 | -100.16% |
| Q4 2022 | 68.98% |
| Q3 2022 | 585.31% |
| Q2 2022 | 117.35% |
| Q1 2022 | -1.65% |
| Q4 2021 | -8.08% |
| Q3 2021 | -16.62% |
| Q2 2021 | -96.41% |
| Q1 2021 | 50.09% |
| Q4 2020 | 0.00% |